ONCOLOGY

Staging the patient’s physiological state using derivative SIR biomarkers is important.

Delivering oesophago-gastric cancer care during the COVID-19 pandemic at a high-volume tertiary centre in the UK

Findings from a multicenter, randomized controlled trial.

A cell-collection device that can be used in primary care.

Less toxicity in esophageal cancer.

Findings from a phase 2B RCT.

Does local tumour response translate to survival benefit?

Lung, breast, colorectal, esophageal cancer deaths are all expected to rise.

The prevalence of GERD with weekly symptoms is 10%-20% in Europe and North America.

Treatment options are limited for advanced-stage ESCC.

Results conflict with trial findings of fewer pulmonary complications with MIE.

Findings in matched analysis strengthen confidence in observational results.

Meta-analysis of observational studies confirms the association.

The device could be a non-invasive diagnostic tool to screen primary care patients before referral for endoscopy.